Howard Robin Net Worth & Insider Trades

Howard Robin - President & CEO, Nektar Therapeutics

As of November 20, 2023

What is Howard Robin's Net Worth?

The current estimated net worth of Nektar Therapeutics's President & CEO, Howard Robin, is estimated to be about $96.99M . Howard Robin owns about 900,332 units of Nektar Therapeutics common stock. In the last 16 years at Nektar Therapeutics, Howard Robin has sold an estimated value of $101.18M worth.

What is Howard Robin's Past Insider Trading?

Howard Robin's largest purchase order was 600,000 units , worth over $8.71M on November 26, 2014. Howard Robin's largest sale order was 130,000 units , worth over $10.93M on May 3, 2018. In total, Howard Robin has made about 79 transactions over 16 years of their time at Nektar Therapeutics. Howard Robin usually trades in February, with the busiest year in 2016 and 2017. The most recent transaction was a sale order of 19,877 units , worth over $9.74K on November 20, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Nektar Therapeutics's Past Insider Trades?

Nektar Therapeutics's most recent insider trade came on November 20, 2023 by Jonathan Zalevsky who sold 9,646 units worth $4.73K . In the last 20 years, insiders at Nektar Therapeutics have sold an estimated value of $295.38M and bought an estimated value of $84.98M worth of shares. Insider trading is most common in September, with the busiest year in 2017 and 2016. The most active traders at the company are Howard Robin, President & CEO,  Gil Labrucherie, SVP,  and Robert Chess, Director .

NEKTAR THERAPEUTICS Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...